ASND (Ascendis Pharma A/S Ordinary Share) Stock Analysis - Hedge Fund Holdings

Ascendis Pharma A/S Ordinary Share (ASND) is a publicly traded Healthcare sector company. As of May 21, 2026, ASND trades at $241.34 with a market cap of $14.68B and a P/E ratio of 0.00. ASND moved +1.47% today. Year to date, ASND is +13.23%; over the trailing twelve months it is +49.37%. Its 52-week range spans $118.03 to $250.74. Analyst consensus is strong buy with an average price target of $299.17. Rallies surfaces ASND's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ASND stock?

Hedge funds tracked by Rallies that own ASND include Orbimed Advisors, Duquesne Family, Soros Fund, Eisler Capital, and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Ascendis Pharma A/S Ordinary Share.

ASND Key Metrics

Key financial metrics for ASND
MetricValue
Price$241.34
Market Cap$14.68B
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$250.74
52-Week Low$118.03
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Top Hedge Funds Holding ASND

  • Orbimed Advisors holds 181.98K shares of ASND, changed +5.81% as of Mar 31, 2026.
  • Duquesne Family holds 158.72K shares of ASND, changed -40.11% as of Mar 31, 2025.
  • Soros Fund holds 100.00K shares of ASND, changed +2813.75% as of Jun 30, 2024.
  • Eisler Capital holds 6.08K shares of ASND, changed +0.00% as of Jun 30, 2024.
  • Centerbook Partners holds 6.01K shares of ASND, changed -44.86% as of Mar 31, 2026.

Latest ASND News

Recent ASND Insider Trades

  • JENSEN FLEMMING STEEN sold 19.46K (~$4.64M) on May 11, 2026.

ASND Analyst Consensus

12 analysts cover ASND: 0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $299.17.

Common questions about ASND

Who owns ASND stock?
Hedge funds tracked by Rallies that own ASND include Orbimed Advisors, Duquesne Family, Soros Fund, Eisler Capital, and Centerbook Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Ascendis Pharma A/S Ordinary Share.
Does Rallies show 13F holders for ASND?
Yes. Rallies tracks hedge fund and 13F ownership data for ASND, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ASND research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ASND. It does not provide personalized investment advice.
ASND

ASND